Biomerica, Inc.
BMRA · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $1,380 | $749 | $1,119 | $1,636 |
| % Growth | 84.2% | -33.1% | -31.6% | – |
| Cost of Goods Sold | $956 | $993 | $1,100 | $1,199 |
| Gross Profit | $424 | -$244 | $19 | $437 |
| % Margin | 30.7% | -32.6% | 1.7% | 26.7% |
| R&D Expenses | $212 | $252 | $217 | $257 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,330 | $1,068 | $1,012 | $1,173 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,542 | $1,320 | $1,229 | $1,430 |
| Operating Income | -$1,118 | -$1,564 | -$1,210 | -$993 |
| % Margin | -81% | -208.8% | -108.1% | -60.7% |
| Other Income/Exp. Net | $1,123 | $25 | $43 | $40 |
| Pre-Tax Income | $5 | -$1,539 | -$1,167 | -$953 |
| Tax Expense | $3 | $5 | -$4 | -$3 |
| Net Income | $2 | -$1,544 | -$1,163 | -$950 |
| % Margin | 0.1% | -206.1% | -103.9% | -58.1% |
| EPS | 0.003 | -0.16 | -0.068 | -0.056 |
| % Growth | 101.9% | -135.6% | -22.3% | – |
| EPS Diluted | 0.003 | -0.16 | -0.068 | -0.056 |
| Weighted Avg Shares Out | 2,639 | 9,709 | 17,121 | 17,121 |
| Weighted Avg Shares Out Dil | 2,639 | 9,709 | 17,121 | 17,121 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,123 | $25 | $43 | $40 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $102 | $104 | $99 | $0 |
| EBITDA | $107 | -$1,460 | -$1,111 | -$993 |
| % Margin | 7.8% | -194.9% | -99.3% | -60.7% |